Given the current Coronavirus situation, I believe it appropriate to reassure you that Deepbridge has robust contingency plans in place to ensure we can continue to operate as normal as best we can. These plans have already been enacted and we shall continue to review and take further steps according to Government advice.
In short, we have robust systems in place and therefore all of our teams have the ability to work remotely. Therefore, financial advisers and clients should experience no change in service-levels.
If you or your client is looking to invest before the end of the tax year, and can do so, we encourage the use of bank transfers rather than submitting cheques.
We appreciate that not every client will be able to make a bank transfer, but if they can then this is highly recommended.
The Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS usually deploy funds on a monthly basis, with further deployments expected between now and the 5 April 2020.
Please note that deployment in the 2019/20 tax year is subject to the closing date of 26th March for receipt of fully completed applications and cleared funds. (For any client considering utilising carry back for the 2018/19 tax year, deployment prior to 5 April 2020 is essential.)
This highlights the potential advantage, especially at this time of the year, of recommending a provider which usually deploys funds on a monthly basis.
Ian Warwick, Managing Partner, Deepbridge Capital
- May 2024 (2)
- April 2024 (2)
- March 2024 (3)
- February 2024 (8)
- January 2024 (7)
- December 2023 (1)
- November 2023 (7)
- October 2023 (6)
- September 2023 (4)
- August 2023 (4)
- July 2023 (7)
- June 2023 (5)
- May 2023 (3)
- April 2023 (4)
- March 2023 (1)
- February 2023 (2)
- January 2023 (3)
- December 2022 (3)